How to buy GenusPlus shares | GNP historical share price and analysis

How to buy GenusPlus shares

Own GenusPlus shares in just a few minutes.

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

GenusPlus Group Limited is an engineering & construction business based in Australia. GenusPlus shares (GNP) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. GenusPlus has a trailing 12-month revenue of around $221.8 million.

How to invest in the GenusPlus IPO

To invest in an IPO, you'll usually need to be registered with a participating broker or lead manager. This can be tricky for retail investors because there are usually only a few firms allocated for each IPO and they're typically full-service stockbrokers. In this case, the lead manager is Bell Potter.

If you're already registered with a broker, it always pays to check if they're offering IPO stock, as lead managers sometimes allocate a portion of shares on to other firms. Your other option is to buy shares in GenusPlus once it goes public. To do that, you'll need to be signed up to a share trading platform:

How to buy shares when GenusPlus lists

  1. Compare share trading platforms. To buy shares in an Australian-listed company, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for GenusPlus. Find the share by name or ticker symbol: GenusPlus. You can also search for any other shares traded publicly on exchanges available within your chosen platform.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until GenusPlus reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At price of at you're buying the shares, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of GenusPlus. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

GenusPlus share price

Use our graph to track the performance of GNP stocks over time.

GenusPlus shares at a glance

Information last updated 2021-03-09.
52-week range$0.95 - $1.12
50-day moving average $1.0139
200-day moving average $1.0198
Target priceN/A
PE ratio 16.2712
Dividend yield N/A (0%)
Earnings per share (TTM) $0.059

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Data updated regularly
Name Product Standard brokerage fee Inactivity fee Markets
Superhero share trading
AUD $5
ASX shares, ETFs
Pay zero brokerage on all Australian ETFs.
Trade ASX stocks with a flat $5 commission fee and a low minimum investment of just $100.
Bell Direct Share Trading
AUD $15
ASX shares, mFunds, ETFs
Exclusive: New customers who open an account with Bell Direct through Finder will pay no brokerage fees on the first five stock or ETF trades until April 30, 2021 (T&Cs apply).
Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.
IG Share Trading
Finder Award
IG Share Trading
AUD $8 or 0.1%
$50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
CMC Markets Stockbroking
AUD $11 or 0.1%
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
ANZ Share Investing
AUD 19.95
ASX shares, Global shares, Options trading, mFunds, ETFs, Warrants
Earn 1 Qantas Point per AU$3 spent on brokerage fees on certain instruments.
Access Morningstar reports, company announcements and and live pricing via ANZ’s share investing platform. Available for desktop and mobile.
Westpac Online Investing Account
AUD 19.95 or 0.11%
USD 63.50 per year on the global markets account
ASX shares, Global shares, Options trading, ETFs

Compare up to 4 providers

Is it a good time to buy GenusPlus stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Is GenusPlus under- or over-valued?

Valuing GenusPlus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of GenusPlus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

GenusPlus's P/E ratio

GenusPlus's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, GenusPlus shares trade at around 16x recent earnings.

That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

GenusPlus's EBITDA

GenusPlus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14.7 million (£0.0 million).

The EBITDA is a measure of a GenusPlus's overall financial performance and is widely used to measure a its profitability.

GenusPlus financials

Revenue TTM $221.8 million
Operating margin TTM 4.31%
Gross profit TTM $125.2 million
Return on assets TTM 7.37%
Return on equity TTM 31.46%
Profit margin 4.13%
Book value 0.319
Market capitalisation $148.6 million

TTM: trailing 12 months

GenusPlus share dividends

We're not expecting GenusPlus to pay a dividend over the next 12 months.

GenusPlus overview

GenusPlus Group Limited provides infrastructure services in Australia. The company's services cover power and telecommunications transmission and distribution; underground network installation services, which range from optic fiber for telecommunications to underground power and civil works; switchyards, substation, communications, and renewable energy; design, construction, commissioning, fault works, and maintenance; high voltage (HV) testing, commissioning, and engineering services, including HV cable jointing, HV testing, protection relay testing, fault location, and high voltage maintenance; electrical and instrumentation services; and construction and maintenance. It also provides integrated engineering and training, and related support services. The company provides its services for customers in the infrastructure, utilities, mining and resources, government and private, telecommunications, power distribution and generation, commercial, industrial, civil, and oil and gas sectors. GenusPlus Group Limited was incorporated in 2017 and is headquartered in Belmont, Australia.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site